Characterization of Neuromuscular Function and Fatigue After Breast Cancer Treated With Adjuvant Chemotherapy (PROTECT-04)

Inclusion Criteria : Group 1 - Patients : * Give written inform consent * Age ≥ 18 years * Affiliate to social security system * Ability to speak, understand and read French * Breast cancer, Stage II or III, treated by taxane-based chemotherapy Group 2 - Control group : * Give written inform consent * Age ≥ 18 years * Affiliate to social security system * Ability to speak, understand and read French Exclusion Criteria: Group 1 - Patients : * \< 18 years old or patients ≥ 18 years old under guardianship, or supervision * Psychiatric, musculoskeletal or neurologic disorders * Patients presenting one of the following contraindications to transcranial magnetic stimulation : * Presence of a implanted metallic foreign-body (cochlear implant, drug pump system, pacemaker, etc.) * History of epilepsy * Brain injury (vascular, traumatic, tumour-induced, infectious or metabolic) * Women that are pregnant * Serious or recent heart disease Group 2 -Control group : * \< 18 years old or patients ≥ 18 years old under guardianship, or supervision * Psychiatric, musculoskeletal or neurologic disorders * Pacemaker implantation * History of cancer * All known chronic disease * Subjects presenting one of the following contraindications to transcranial magnetic stimulation : * Presence of a implanted metallic foreign-body (cochlear implant, drug pump system, pacemaker, etc.) * History of epilepsy * Brain injury (vascular, traumatic, tumour-induced, infectious or metabolic) * Women that are pregnant * Serious or recent heart disease